Original language | English (US) |
---|---|
Pages (from-to) | e433-e435 |
Number of pages | 3 |
Journal | EuroIntervention |
Volume | 17 |
Issue number | 5 |
DOIs | |
State | Published - Aug 2021 |
Keywords
- Chronic Disease
- Computed Tomography Angiography
- Coronary Angiography
- Coronary Occlusion/diagnostic imaging
- Fluoroscopy
- Humans
- Percutaneous Coronary Intervention
- Tomography, X-Ray Computed
- Treatment Outcome
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: EuroIntervention, Vol. 17, No. 5, 08.2021, p. e433-e435.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions
AU - Xenogiannis, Iosif
AU - Jaffer, Farouc A.
AU - Shah, Alpesh R.
AU - Omer, Mohamed
AU - Megaly, Michael
AU - Vemmou, Evangelia
AU - Nikolakopoulos, Ilias
AU - Rangan, Bavana V.
AU - Garcia, Santiago
AU - Lesser, John R.
AU - Cavalcante, João L.
AU - Burke, M. Nicholas
AU - Brilakis, Emmanouil S.
N1 - Funding Information: F. Jaffer reports research grants (Siemens, Canon, Shockwave), consulting (Boston Scientific, Abbott Vascular, Philips), speaker’s fees (Biotronik, Siemens), equity interest (Intravascular Imaging, Inc.), and American College of Cardiology (Associate Editor, JACC Cardiovascular Imaging). In addition, F. Jaffer has an intravascular imaging-related patent. B. Rangan reports research grants from Infraredx, Inc., and The Spectranetics Corporation. S. Garcia reports grants from BSCI, and Edwards Lifesciences, and personal fees from Abbott Vascular, Medtronic and Edwards Lifesciences, outside the submitted work. J.L. Cavalcante reports being on the speaker’s bureau for Siemens Healthineers. N. Burke reports being a shareholder in Egg Medical and MHI Ventures, being a speaker for Opsens Medical, and receiving consulting and speaker honoraria from Abbott Vascular and Boston Scientific. E. Brilakis reports consulting/speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor, Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Elsevier, Infraredx, GE Healthcare, Medicure, Medtronic, Opsens, Siemens, and Teleflex, and being a shareholder in MHI Ventures and Cleerly Health. The other authors have no conflicts of interest to declare.
PY - 2021/8
Y1 - 2021/8
KW - Chronic Disease
KW - Computed Tomography Angiography
KW - Coronary Angiography
KW - Coronary Occlusion/diagnostic imaging
KW - Fluoroscopy
KW - Humans
KW - Percutaneous Coronary Intervention
KW - Tomography, X-Ray Computed
KW - Treatment Outcome
UR - http://www.scopus.com/inward/record.url?scp=85113296173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113296173&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-20-00175
DO - 10.4244/EIJ-D-20-00175
M3 - Article
C2 - 32657275
AN - SCOPUS:85113296173
SN - 1774-024X
VL - 17
SP - e433-e435
JO - EuroIntervention
JF - EuroIntervention
IS - 5
ER -